Your browser doesn't support javascript.
loading
Real-world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) study.
Peretz Soroka, Hagit; Vora, Tushar; Noujaim, Jonathan; Marcoux, Nicolas; Cohen-Gogo, Sarah; Alcindor, Thierry; Holloway, Caroline; Rodrigues, Caroline; Karachiwala, Hatim; Alvi, Saima; Lee, Ursula; Cheng, Sylvia; Banerji, Shantanu; Oberoi, Sapna; Feng, Xiaolan; Smrke, Alannah; Simmons, Christine; Razak, Albiruni Abdul; Gupta, Abha A.
Afiliación
  • Peretz Soroka H; Division of Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
  • Vora T; Division of Hematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Noujaim J; Division of Medical Oncology, Hôpital Maisonneuve Rosemont, University of Montreal, Montreal, Quebec, Canada.
  • Marcoux N; Division of Hematology-Oncology, Centre Hospitalier Universitaire de Québec, Quebec, Canada.
  • Cohen-Gogo S; Division of Hematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Alcindor T; Division of Medical Oncology, McGill University Health Centre, Montreal, Quebec, Canada.
  • Holloway C; Division of Radiation Oncology, BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada.
  • Rodrigues C; Division of Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
  • Karachiwala H; Division of Medical Oncology, Cross Cancer Institute, Alberta Health Services, Edmonton, Alberta, Canada.
  • Alvi S; Division of Pediatric Hematology/Oncology, Jim Pattison Children's Hospital Saskatoon, Saskatoon, Saskatchewan, Canada.
  • Lee U; Division of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada.
  • Cheng S; Division of Pediatric Hematology/Oncology/BMT, B.C. Children's Hospital, BC Cancer, Vancouver, British Columbia, Canada.
  • Banerji S; Department of Pediatric Hematology-Oncology, CancerCare Manitoba Research Institute, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Oberoi S; Department of Pediatric Hematology-Oncology, CancerCare Manitoba Research Institute, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Feng X; Division of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada.
  • Smrke A; Division of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada.
  • Simmons C; Division of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada.
  • Razak AA; Division of Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
  • Gupta AA; Division of Medical Oncology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
Cancer Med ; 12(18): 18872-18881, 2023 09.
Article en En | MEDLINE | ID: mdl-37724607

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sarcoma / Sarcoma de Ewing / Neoplasias de los Tejidos Blandos / Neoplasias Óseas / Osteosarcoma / Condrosarcoma Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Child / Humans / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sarcoma / Sarcoma de Ewing / Neoplasias de los Tejidos Blandos / Neoplasias Óseas / Osteosarcoma / Condrosarcoma Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Child / Humans / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article País de afiliación: Canadá